SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: James Reynolds who wrote (7)2/6/1998 12:55:00 PM
From: IMW  Read Replies (1) | Respond to of 447
 
OSIP is heavily (34%) owned by institutions.
Their ins and outs may be the cause of what you are referring to. I noticed it took relatively little volume in Jan. to run it up from where we are now to 8 1/4. This is the only company in this sector that I own and I am impressed with the quality of their affiliations, their patent estate, and their diversity.